全文获取类型
收费全文 | 105563篇 |
免费 | 5467篇 |
国内免费 | 52篇 |
专业分类
林业 | 4322篇 |
农学 | 3039篇 |
基础科学 | 729篇 |
11688篇 | |
综合类 | 20732篇 |
农作物 | 4294篇 |
水产渔业 | 4621篇 |
畜牧兽医 | 54347篇 |
园艺 | 1195篇 |
植物保护 | 6115篇 |
出版年
2018年 | 1205篇 |
2017年 | 1334篇 |
2016年 | 1285篇 |
2015年 | 1092篇 |
2014年 | 1263篇 |
2013年 | 3931篇 |
2012年 | 2569篇 |
2011年 | 3185篇 |
2010年 | 2077篇 |
2009年 | 2056篇 |
2008年 | 3208篇 |
2007年 | 2940篇 |
2006年 | 2803篇 |
2005年 | 2640篇 |
2004年 | 2745篇 |
2003年 | 2678篇 |
2002年 | 2622篇 |
2001年 | 3272篇 |
2000年 | 3288篇 |
1999年 | 2440篇 |
1998年 | 1071篇 |
1997年 | 1081篇 |
1995年 | 1255篇 |
1994年 | 1164篇 |
1993年 | 1121篇 |
1992年 | 2362篇 |
1991年 | 2530篇 |
1990年 | 2438篇 |
1989年 | 2495篇 |
1988年 | 2273篇 |
1987年 | 2350篇 |
1986年 | 2484篇 |
1985年 | 2395篇 |
1984年 | 1920篇 |
1983年 | 1773篇 |
1982年 | 1166篇 |
1981年 | 1123篇 |
1980年 | 1025篇 |
1979年 | 1762篇 |
1978年 | 1424篇 |
1977年 | 1147篇 |
1976年 | 1130篇 |
1975年 | 1165篇 |
1974年 | 1524篇 |
1973年 | 1612篇 |
1972年 | 1584篇 |
1971年 | 1517篇 |
1970年 | 1409篇 |
1969年 | 1262篇 |
1967年 | 1094篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Efficacy of a mephentermine‐based product as a vasopressor and a cardiac performance enhancer when given intramuscularly to cattle 下载免费PDF全文
D. N. Q. Cunha C. L. del Rio B. L. Youngblood E. L. Ferris G. E. Geist Y. Ueyama L. C. Franz S. Mathur R. L. Hamlin 《Journal of veterinary pharmacology and therapeutics》2018,41(2):274-280
The goal of this study was to confirm the vasopressor and cardiac effects of POTENAY® INJETÁVEL (POT), a mephentermine‐based product, given to cattle with induced vascular/cardiac depression. Ten healthy Holstein cattle (206 ± 13 kg) followed a randomized‐complete‐block design (RCBD) utilizing crossover study design. Each animal randomly received (1 ml/25 kg, IM) of either POT (n = 10) or volume‐matched placebo control (0.9%NaCl, CP, n = 10). A subset of animals (n = 5) received POT first (day 0) while the remaining (n = 5) received CP; after a six‐day washout period, cattle received the opposite compound. Animals were anesthetized and catheterized for systemic/left ventricular hemodynamic monitoring. Myocardial dysfunction/hypotension was induced by increasing the end‐tidal isoflurane concentration until arterial blood pressure was 20% lower than at baseline and remained stable. Once the animal was determined to be hypotensive and hemodynamically stable, steady‐state hypotensive baseline data (BL2) were acquired, and treatment with either POT or CP was given. Data were acquired post‐treatment at every 15 min for 90 min. POT improved cardiac output (+68 L/min, ±14%, p < 0.05), MAP (+14 mmHg, ±4%, p < 0.05), HR (+22 bpm, ±8%, p < 0.05), and peak rates of ventricular pressure change during both systole (dP/dtmax: +37 mmHg/s ±13%, p < 0.05) and diastole (dP/dtmin: +31 mmHg/s, ±7%, p < 0.05). No improvements were noted following placebo‐control administration. Results indicate that POT improves cardiac performance and systemic hemodynamics in cattle with induced cardiovascular depression when given as single intramuscular injection. 相似文献
992.
Effect of dasatinib in a xenograft mouse model of canine histiocytic sarcoma and in vitro expression status of its potential target EPHA2 下载免费PDF全文
K. Ito R. Miyamoto H. Tani S. Kurita M. Kobayashi K. Tamura M. Bonkobara 《Journal of veterinary pharmacology and therapeutics》2018,41(1):e45-e48
Canine histiocytic sarcoma (HS) is an aggressive and highly metastatic tumor. Previously, the kinase inhibitor dasatinib was shown to have potent growth inhibitory activity against HS cells in vitro, possibly via targeting the EPHA2 receptor. Here, the in vivo effect of dasatinib in HS cells was investigated using a xenograft mouse model. Moreover, the expression status of EPHA2 was examined in six HS cell lines, ranging from insensitive to highly sensitive to dasatinib. In the HS xenograft mouse model, dasatinib significantly suppressed tumor growth, as illustrated by a decrease in mitotic and Ki67 indices and an increase in apoptotic index in tumor tissues. On Western blot analysis, EPHA2 was only weakly detected in all HS cell lines, regardless of sensitivity to dasatinib. Dasatinib likely results in the inhibition of xenograft tumor growth via a mechanism other than targeting EPHA2. The findings of this study suggest that dasatinib is a targeted therapy drug worthy of further exploration for the treatment of canine HS. 相似文献
993.
A. Rezaeenia A. A. Naserian R. Valizadeh A. M. Tahmasbi A. Mokhtarpour 《Tropical animal health and production》2018,50(7):1427-1433
The objective of this experiment was to investigate the influence of ground date seed (GDS) on intake, digestibility, and milk yield and milk fatty acid (FA) composition of lactating Holstein cows. The experimental design was a 4?×?4 replicated Latin square with eight lactating dairy cows with an average milk production of 35.5?±?1.5 kg and 75?±?5 days in milk (DIM). Dairy cows were fed one of the four treatments contained 0, 2, 4, and 6% of diet dry matter (DM) GDS in replacement of wheat bran. All diets contained the same amount of forages (alfalfa hay and corn silage). Dietary treatments had no effect on DM intake (DMI), total tract apparent digestibility, milk yield, and milk composition. Increasing GDS linearly decreased concentration of C13:0 and increased cis-9 C14:1 and trans-11 C18:1 (vaccenic acid) (P?<?0.05). A linear tendency for more C16:1 content in milk fat was observed with increasing GDS (P?=?0.06). Feeding GDS resulted in a linear decrease (P?<?0.01) in saturated FA (SFA) but increased milk fat monounsaturated FA (MUFA) and trans FA (TFA) (P?<?0.05). Therefore, low levels of GDS (up to 6%) in the diet of Holstein dairy cows can beneficially modify milk FA composition without any adverse effects on intake, digestibility, and milk yield. 相似文献
994.
V. Arthy R. Venkataramanan S. N. Sivaselvam C. Sreekumar D. Balasubramanyam 《Tropical animal health and production》2018,50(7):1463-1471
The Network Project on Sheep Improvement (NWPSI)–Madras Red field unit is a group breeding scheme involving 198 farmers’ flocks of Madras Red sheep in which selection for growth traits and rotation of rams have been practised for over two decades. Growth data collected from these flocks were used to evaluate the performance and understand the direct and expected responses to selection based on genetic parameters. The body weight at birth (BW), weaning weight (WW), 6-month weight (6W), 9-month weight (9W), 12-month weight (YW), pre-weaning average daily gain (ADG1, birth to 3 months), post-weaning ADG2 (3–6 months), ADG3 (6–9 months), ADG4 (9–12 months) and ADG5 (3–12 months) were 2.67, 10.05, 14.56, 18.36, 21.36, 80.13, 49.05, 43.00, 34.21 and 41.18 g, respectively. Univariate analyses were carried out using animal and sire models to estimate variance components. Heritability obtained from animal model for BW was 0.36 and the values for other body weight traits were almost unity. Heritability estimate for pre-weaning ADG1 was 0.31. Very high genetic variability was observed in spite of long-term selection and this sustenance of variability is one of the main advantages of a group breeding scheme, combining several flocks of smaller size. An increasing genetic and phenotypic trend was noticed for almost all the traits studied. The expected responses calculated based on genetic parameters also indicated scope for improvement. 相似文献
995.
In vitro anti‐LPS dose determination of ketorolac tromethamine and in vivo safety of repeated dosing in healthy horses 下载免费PDF全文
A. W. Bianco G. E. Moore B. R. Cooper S. D. Taylor 《Journal of veterinary pharmacology and therapeutics》2018,41(1):98-104
Flunixin meglumine (FM) is a commonly used Nonsteroidal anti‐inflammatory drug (NSAID) in horses, but clinical efficacy is often unsatisfactory. Ketorolac tromethamine (KT) demonstrates superior efficacy compared to other NSAIDs in humans, but its anti‐inflammatory effects have not been investigated in the horse. Safety of repeated dosing of KT has not been evaluated. The first objective was to conduct a dose determination study to verify that a previously described dosage of KT would inhibit Lipopolysaccharide (LPS)‐induced eicosanoid production in vitro, and to compare KT effects of this inhibition to those of FM. Then, a randomized crossover study was performed using nine healthy horses to evaluate plasma concentrations of KT and FM following IV administration. Administered dosages of KT and FM were 0.5 mg/kg and 1.1 mg/kg, respectively. Safety following six repeated doses of KT was assessed. Ketorolac tromethamine and FM suppressed LPS‐induced Thromboxane B2 (TXB2) and Prostaglandin E2 (PGE2) production in vitro for up to 12 hr. Intravenous administration produced plasma concentrations of KT and FM similar to previous reports. No adverse effects were observed. A KT dosage of 0.5 mg/kg IV inhibited LPS‐induced eicosanoids in vitro, and repeated dosing for up to 3 days appears safe in healthy horses. Investigation of in vivo anti‐inflammatory and analgesic effects of KT is warranted. 相似文献
996.
997.
R Le Get 《Australian veterinary journal》2018,96(8):285-290
When contagious bovine pleuropneumonia (CBPP) was first detected on a farm north of Melbourne, at Bundoora, in 1858, the predominant theory of miasma was being challenged by contagionist theories of disease transmission. This well‐documented case was recorded during a period of change in the scientific assessment of disease and therefore affords an exploration of what aspects of the landscape were considered important for livestock health at the time. Although the introduction, vaccination programs and eventual eradication of CBPP on mainland Australia has been well explored, scholars have neglected this aspect of the disease's history. By comparing 19th century records of farmland with how the site appears today, it is also possible to highlight the limited information provided by contemporary texts, while at the same time developing an appreciation of the ways in which the perception of the rural landscape has changed. This differing perception has implications for the utilisation of these sources for veterinary and environmental historians seeking to understand the mid‐19th century agricultural landscape and how it relates to animal health. 相似文献
998.
999.
C. Ruíz-Guevara F. De León-González R. Soriano-Robles A. L. Pérez-Carrera L. A. García-Hernández 《Tropical animal health and production》2018,50(3):469-476
The dual-purpose bovine system represents 98.4% of the bovine livestock of Veracruz, the main cattle-producing state of Mexico. This system supplies calves to meat companies, a sector in which Veracruz has been the national leader in the last decade. The objective of the present study was to analyze the effect of the altitudinal zonation of farms on livestock technology and productivity in a microbasin of the Gulf of Mexico where small farms predominate. Structured interviews were applied to producers located in three altitudinal zones (at average altitudes of 50, 140, and 450 m, respectively, for lower, middle, and upper zones). Sample size was 135 farms having similar land surface (within a range of 15–22 ha). The results indicated multiple differences among farms located in the three zones. Farms in the middle and lower zones presented higher productive indicators than those in the upper zone. Differences in herd structure and management resulted in important differences in productivity, income, and profits in milk and calf production. We concluded from this study that altitudinal zonation in Veracruz had a clear effect on the differentiation of small farms, which are representative of dual-purpose cattle. The upper zone performs cattle activity under conditions with greater disadvantages in the analyzed region. 相似文献
1000.
Network on veterinary medicines initiated by the European Federation For Pharmaceutical Sciences 下载免费PDF全文
L. Dencker R. T. Cristina H. Linden I. Schmerold 《Journal of veterinary pharmacology and therapeutics》2018,41(3):378-383
The European Federation for Pharmaceutical Sciences (EUFEPS) was founded 25 years ago by more than 20 national pharmaceutical societies and faculty members. As a pan‐European organization, it brings together pharmaceutical societies as well as academic, industrial and regulatory scientists engaged in drug research and development, drug regulation and education of professionals working in these fields. EUFEPS represents pharmaceutical sciences in Europe and is recognized as such by both the European Commission and the European Medicines Agency. EUFEPS cooperates with the European Federation of Pharmaceutical Industries and other European organizations and maintains global connections with agencies such as the US Food and Drug Administration and the American Association of Pharmaceutical Scientists. EUFEPS has established specified networks forming the basis of its activities. The creation of a Network on Veterinary Medicines is prompted by the manifold problems resulting from the use of veterinary drugs and its inherent interconnections with human medicine, environmental and public health. A long‐term goal of this initiative was to expand the spectrum of available therapeutics for use in animals, including the development of innovative delivery systems. 相似文献